(Reuters)—President Donald Trump’s nominee to lead the U.S. Food and Drug Administration, Dr. Scott Gottlieb, was questioned about his ties to the pharmaceutical industry by Democrats on a key Senate committee on Wednesday ahead of a vote on whether to advance his nomination for a vote by the full Senate. Gottlieb, 44, is a former…
Let Your Voice Be Heard
Rheumatology is a relatively small subspecialty, but our patients need us to be strong advocates for them, ensuring access to the care they need. That’s why the ACR is calling on all of our members to join the American Medical Association (AMA) or renew your membership. Without a unified voice, we have no voice. We’ve…
The ACR Advocates for More MIPS Points for RISE Use
On behalf of the rheumatology community, the ACR recently submitted an entry for a rheumatology-specific Clinical Practice Improvement Activity (CPIA) that, if accepted, will be included in the 2018 performance year. The CMS put a call out to the public for CPIAs in an attempt to make MACRA more meaningful for participating providers. The ACR…

S.C. Rheumatism Society Benefits from ACR Partnership
Editor’s note: This article will be the first in a series of articles highlighting the advocacy work done by state and local societies around the country. The South Carolina Rheumatism Society (SCRS) realizes multiple benefits from its association with the ACR, according to Jeffrey G. Lawson, MD, the society’s treasurer. One example of the support offered:…
CORC: The Uncomfortable Move from Fee for Service to Value
ACR members are spread out across the U.S., but we all work in the same place: the land of fee for service. FFS, as it’s known to policy nerds, poses certain problems for cognitive subspecialists like rheumatologists. For instance, much of the work we do—calling providers and patients, coordinating care after hours—often isn’t compensated. And…
2017 Proves There’s ‘Power in Numbers’
RheumPAC’s first quarter progress indicates that it’s right on track to meet its monetary goals, but it’s not just about the money.

Sirukumab Promising for RA
In a clinical trial, RA patients on sirukumab experienced decreased disease activity and improved physical function…

Do You Have What It Takes to Be an Educator?
Two rheumatologists share why they became educators, the challenges they face and what keeps them teaching young physicians…

Brain Stimulation May Help with Fibromyalgia
New research examined the use of transcranial direct current stimulation over the dorsolateral prefrontal cortex of the brain to modulate attention in patients with fibromyalgia. The study found that the active current increased heat pain threshold and tolerance. However, a regression analysis showed the effect on executive attention appeared to be independent of the effect on pain…
Recommendations for Sjögren’s Syndrome: How to Address Biologics & Musculoskeletal Pain
The clinical practice guidelines for managing Sjögren’s syndrome, developed by the Sjögren’s Syndrome Foundation with the ACR, were designed to improve quality and consistency of care. In total, 19 recommendations were agreed on, which include managing the rheumatic and systemic aspects of the disease. Recommendations include a decision tree for the use of DMARDs for inflammatory musculoskeletal pain, use of self-care measures and exercise to reduce fatigue, and the use of rituximab in selected clinical settings for oral and ocular dryness…
- « Previous Page
- 1
- …
- 433
- 434
- 435
- 436
- 437
- …
- 811
- Next Page »